Lezárult
Research Study Investigating How Well NDec Works in People With Sickle Cell Disease
NCT05405114· 2. fázis· Novo Nordisk A/S· Forrás
Leállították
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
NCT04751383· 1. fázis· National Cancer Institute (NCI)· Forrás
Leállították
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
NCT04158141· 3. fázis· NRG Oncology· Forrás
Lezárult
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)
NCT03971474· 2. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
NCT03813147· 1. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
NCT03845296· 2. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
NCT03768414· 3. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
NCT03526250· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors
NCT03320330· 1/2. fázis· Children's Oncology Group· Forrás
Lezárult
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
NCT03323034· 1. fázis· Children's Oncology Group· Forrás
Lezárult
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
NCT03206450· Children's Oncology Group· Forrás
Lezárult
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
NCT03223753· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
NCT03213678· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
NCT03213665· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
NCT03220035· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
NCT03213691· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma
NCT03033576· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
NCT03233204· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
NCT02975882· 1. fázis· Children's Oncology Group· Forrás
Lezárult
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT02844816· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
NCT02717507· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
NCT02470091· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
NCT02323880· 1. fázis· Children's Oncology Group· Forrás
Leállították
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
NCT02408861· 1. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
NCT02180867· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
NCT01979536· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
NCT01798004· 1. fázis· Children's Oncology Group· Forrás
Lezárult
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
NCT01809691· 3. fázis· SWOG Cancer Research Network· Forrás
Lezárult
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
NCT01553149· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
NCT01602666· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
NCT02883049· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
NCT01503632· 3. fázis· Children's Oncology Group· Forrás
Lezárult
S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
NCT01224665· SWOG Cancer Research Network· Forrás
Lezárult
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT01371981· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
NCT01236560· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
NCT01231906· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
NCT01190930· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
NCT01096368· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
NCT00980460· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
NCT00945009· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
NCT00653068· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
NCT00336024· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
NCT00392327· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
NCT00379340· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
NCT00352534· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
NCT00107198· 2. fázis· Children's Oncology Group· Forrás
Showing 50 of 57.